Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGb Group Regulatory News (GBG)

Share Price Information for Gb Group (GBG)

Share Price is delayed by 15 minutes
Get Live Data
204.00    0.00 (0.00%)
Bid:
195.00
Ask:
0.00
Spread: 11.00 (5.641%)
Market Cap: £471.17m
GBG Live PriceLast checked at - London Stock Exchange

Intraday Gb Group Share Chart

Director/PDMR Shareholding

2 Jun 2015 15:46

RNS Number : 9932O
GB Group PLC
02 June 2015
 



 

 

 

2 June 2015

 

 

GB Group PLC

 

("GBG" or the "Company")

 

Notification of Directors' Interests

 

The Company announces that Richard Law and Dave Wilson (GBGroup's Chief Executive Officer and Group Finance & Operations Director, respectively), have today notified the Company that they have exercised options over a total of 720,889ordinary shares of 2.5p each in the Company ("Ordinary Shares"). Having sold a proportion of the shares they retain a total of 110,000 of the Ordinary Shares exercised. Both of the directors also purchased a total of 121,190 Ordinary Shares whilst Dave Wilson and his wife also disposed of a total of 62,539 Ordinary Shares to make use of capital losses and CGT allowances.

 

The exercise of the options detailed above is in accordance with the rules of the GBGroup's Share Matching Scheme (the "Scheme"). Under the Scheme, the executive directors and certain senior managers have the annual opportunity to elect to invest up to 20% of their annual salary and up to 80% of their annual bonus in Ordinary Shares at market price. Subject to their continued employment, the retention of these shares and the meeting of a demanding financial performance target, the investment will be matched on a gross basis by matching shares issued at an exercise price of 2.5p per share.

 

The principle qualification for vesting of the options detailed above was a growth in earnings per share ("EPS") of at least 25% per annum compound over 3 financial years. The actual compound growth in EPS over the period was 34.7% per annum. The Scheme requires that the options are exercised within 1 year of vesting. The options vested on 1 June 2014 when the Group's annual results for the year ended 31 March 2015 were announced.

 

As detailed above, a proportion of the Ordinary Shares exercised were sold at a price of £2.0525 to cover the exercise costs incurred and tax liabilities arising in respect of the exercise of these options and also compensation for an element of the salary and bonus which was sacrificed in previous years to participate in the Scheme.

 

The shares that were purchased and sold by the Executives were at a price of £2.0525 per share.

 

More specifically:

 

(i) In relation to Mr Law, he exercised options over a total of 469,825 Ordinary Shares and purchased a total of 78,590 Ordinary Shares.

 

Following this notification, Mr Law has:

 

· a beneficial holding of 2,018,320 Ordinary Shares (which represents 1.67% of the issued share capital of the Company); and

 

· options over a maximum of 1,398,416 Ordinary Shares .

 

(ii) In relation to Mr Wilson, he exercised options over a total of 251,064 Ordinary Shares, (retaining 110,000 Ordinary Shares) purchased a total of 121,190 Ordinary Shares and sold a total of 62,539 Ordinary Shares.

 

Following this notification, Mr Wilson has:

 

· a beneficial holding of 314,032 Ordinary Shares (which represents 0.26% of the issued share capital of the Company); and

 

· options over a maximum of 793,282 Ordinary Shares .

 

-Ends-

 

For further information, please contact:

 

GB Group plc

01244 657333

Richard Law, Chief Executive

Dave Wilson, Group Finance & Operations Director

Peel Hunt LLP (Nominated Adviser and Broker)

020 7418 8900

Richard Kauffer

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUGUCCQUPAGCP
Date   Source Headline
8th Jun 20263:47 pmRNSTransaction in Own Shares
5th Jun 20269:20 amRNSPDMR notification
4th Jun 20269:37 amRNSHolding(s) in Company
2nd Jun 20263:50 pmRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSFull year results for the year ended 31 March 2026
1st Jun 202610:38 amRNSTotal Voting Rights
1st Jun 202610:37 amRNSAdmission to Trading
26th May 20261:23 pmRNSTransaction in Own Shares
20th May 20261:00 pmRNS-REquifax and GBG Expand Global Partnership
19th May 20264:07 pmRNSHolding(s) in Company
18th May 202611:31 amRNSTransaction in Own Shares
12th May 20269:15 amRNSTransaction in Own Shares
8th May 20264:16 pmRNSHolding(s) in Company
5th May 20262:48 pmRNSHolding(s) in Company
5th May 20269:37 amRNSTransaction in Own Shares
30th Apr 20261:53 pmRNSTOTAL VOTING RIGHTS AND SHARE CAPITAL
30th Apr 20261:52 pmRNSAdmission to Trading
27th Apr 20269:34 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTrading Statement
20th Apr 20269:45 amRNSTransaction in Own Shares
13th Apr 20263:42 pmRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 202612:15 pmRNSTotal Voting Rights
31st Mar 202612:15 pmRNSAdmission to Trading
31st Mar 20267:00 amRNSExtension of Share Repurchase Programme
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSCompletion of a refinancing
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20261:38 pmRNSHolding(s) in Company
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 202612:13 pmRNSHolding(s) in Company
16th Mar 202612:13 pmRNSHolding(s) in Company
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20263:37 pmRNSTotal Voting Rights
27th Feb 20263:36 pmRNSADMISSION TO TRADING

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.